| Myeloid-derived suppressor cells as regulators of the immune system DI Gabrilovich, S Nagaraj Nature reviews immunology 9 (3), 162-174, 2009 | 7550 | 2009 |
| Understanding the tumor immune microenvironment (TIME) for effective therapy M Binnewies, EW Roberts, K Kersten, V Chan, DF Fearon, M Merad, ... Nature medicine 24 (5), 541-550, 2018 | 4132 | 2018 |
| Coordinated regulation of myeloid cells by tumours DI Gabrilovich, S Ostrand-Rosenberg, V Bronte Nature Reviews Immunology 12 (4), 253-268, 2012 | 3838 | 2012 |
| Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells DI Gabrilovich, HL Chen, KR Girgis, HT Cunningham, GM Meny, S Nadaf, ... Nature medicine 2 (10), 1096-1103, 1996 | 3068 | 1996 |
| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ... Nature communications 7 (1), 12150, 2016 | 2506 | 2016 |
| Immunosuppressive strategies that are mediated by tumor cells GA Rabinovich, D Gabrilovich, EM Sotomayor Annu. Rev. Immunol. 25, 267-296, 2007 | 2089 | 2007 |
| Subsets of myeloid-derived suppressor cells in tumor-bearing mice JI Youn, S Nagaraj, M Collazo, DI Gabrilovich The Journal of Immunology 181 (8), 5791-5802, 2008 | 2044 | 2008 |
| The nature of myeloid-derived suppressor cells in the tumor microenvironment V Kumar, S Patel, E Tcyganov, DI Gabrilovich Trends in immunology 37 (3), 208-220, 2016 | 1901 | 2016 |
| Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer B Almand, JI Clark, E Nikitina, J van Beynen, NR English, SC Knight, ... The Journal of Immunology 166 (1), 678-689, 2001 | 1735 | 2001 |
| Myeloid-derived suppressor cells DI Gabrilovich Cancer immunology research 5 (1), 3-8, 2017 | 1639 | 2017 |
| Myeloid-derived suppressor cells coming of age F Veglia, M Perego, D Gabrilovich Nature immunology 19 (2), 108-119, 2018 | 1565 | 2018 |
| Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells T Wang, G Niu, M Kortylewski, L Burdelya, K Shain, S Zhang, ... Nature medicine 10 (1), 48-54, 2004 | 1451 | 2004 |
| Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer S Nagaraj, K Gupta, V Pisarev, L Kinarsky, S Sherman, L Kang, ... Nature medicine 13 (7), 828-835, 2007 | 1374 | 2007 |
| Mechanisms and functional significance of tumour-induced dendritic-cell defects D Gabrilovich Nature Reviews Immunology 4 (12), 941-952, 2004 | 1371 | 2004 |
| History of myeloid-derived suppressor cells JE Talmadge, DI Gabrilovich Nature Reviews Cancer 13 (10), 739-752, 2013 | 1311 | 2013 |
| Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo … D Gabrilovich, T Ishida, T Oyama, S Ran, V Kravtsov, S Nadaf, ... Blood, The Journal of the American Society of Hematology 92 (11), 4150-4166, 1998 | 1264 | 1998 |
| HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment CA Corzo, T Condamine, L Lu, MJ Cotter, JI Youn, P Cheng, HI Cho, ... Journal of Experimental Medicine 207 (11), 2439-2453, 2010 | 1240 | 2010 |
| Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected D Marvel, DI Gabrilovich The Journal of clinical investigation 125 (9), 3356-3364, 2015 | 1088 | 2015 |
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein P Cheng, CA Corzo, N Luetteke, B Yu, S Nagaraj, MM Bui, M Ortiz, ... The Journal of experimental medicine 205 (10), 2235-2249, 2008 | 1068 | 2008 |
| Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species S Kusmartsev, Y Nefedova, D Yoder, DI Gabrilovich The Journal of Immunology 172 (2), 989-999, 2004 | 1038 | 2004 |
